We are pleased to announce that we are partnering with Injective Protocol, a fully decentralized sidechain relayer network, and the first layer-2 decentralized exchange protocol, to make privacy-preserving derivatives trading a reality.
Injective Protocol enables fully decentralized trading without any restrictions, allowing individuals to trade on any derivative market of their choosing. As such it is a protocol largely targeted at enabling DeFi developers to create their own custom applications, particularly decentralized exchanges (DEX). Among Injective’s investors and partners are Pantera Capital and Binance Labs.
Injective’s mission is ‘to create a more free and inclusive financial system through decentralization’ which aligns strongly with our vision of a new financial infrastructure that services everyone with native privacy. full interconnectivity, transparency, and compliance.
This will be accomplished through the development of purpose-built blockchain infrastructures and technologies, as well as expanding our global community.
“The traditional derivative market is valued at trillions of dollars in size and largely accessible only by sophisticated institutions.” said Lily Chao, founder and executive chairperson at Findora, “We are happy to work with Injective to help build an entirely new stack of world-changing tools to shift these markets dramatically.”
We believe that this collaboration is long overdue as our teams have been close and share some DNA, including contributions from Charles Lu. Both projects additionally incorporate features such as cross-chain interoperability into their solutions.
As such, we couldn’t be happier to be working with Injective Protocol to drive the adoption and growth of decentralized finance (DeFi)!